Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera
V617F allele burden reduction than slow titration. Both regimens were safe and well tolerated. Ropeg treatment provides durable Hct control and phlebotomy-independence in a broad PV population, including high-risk patients.
Authors
- Albert Qin (ORCID: https://orcid.org/0000-0001-7610-084X)
- Anthony M. Hunter (ORCID: https://orcid.org/0000-0002-9819-4151)
- Norio Komatsu (ORCID: https://orcid.org/0000-0003-1880-9126)
- Daoxiang Wu
- Abdulraheem Yacoub (ORCID: https://orcid.org/0000-0001-5293-4620)
- Ghaith F. Abu-Zeinah (ORCID: https://orcid.org/0000-0002-1881-3670)
- Kazuya Shimoda (ORCID: https://orcid.org/0000-0002-2555-8188)
- Lucia Masárová (ORCID: https://orcid.org/0000-0001-6624-4196)
- Sung‐Eun Lee (ORCID: https://orcid.org/0000-0002-9810-2050)
- Keita Kirito (ORCID: https://orcid.org/0000-0001-5682-2132)
- Ji Yun Lee (ORCID: https://orcid.org/0000-0002-5835-7219)
- Toshiaki Sato (ORCID: https://orcid.org/0000-0002-0073-3592)
- Han Chiu
- Zhang Lei
- Ruben Mesa
- Yun Lee
- Jie Jin
Institutions
- University of Miyazaki (JP)
- The University of Texas MD Anderson Cancer Center (US)
- Emory University (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Cornell University (US)
- Cancer Institute (WIA) (IN)
- Sinovac Biotech (CN)
- New Generation University College (ET)
- Seoul National University Bundang Hospital (KR)
- Juntendo University (JP)
- St. Mary's Hospital (US)
- Levine Cancer Institute (US)
- National University College (PR)
- EA Pharma (Japan) (JP)
- Cellular Therapeutics (United Kingdom) (GB)
- Institute of Hematology & Blood Diseases Hospital (CN)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- First Affiliated Hospital Zhejiang University (CN)
- Weill Cornell Medicine (US)
- University of Yamanashi (JP)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-07-17
- DOI
- https://doi.org/10.1080/10428194.2026.2699995
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00